Legis Daily

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

USA119th CongressHR-7407| House 
| Updated: 2/5/2026
Frank Pallone

Frank Pallone

Democratic Representative

New Jersey

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill amends the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts related to dietary supplements, aiming to enhance consumer protection and regulatory oversight. It specifically prohibits the introduction or delivery into interstate commerce of any product marketed as a dietary supplement that does not meet the statutory definition of a dietary supplement. This measure seeks to prevent mislabeled or non-compliant products from reaching consumers. Furthermore, the legislation makes it a prohibited act to introduce into commerce a dietary supplement that has been prepared, packed, or held with the assistance or direction of a person debarred under the Act. To strengthen enforcement, the bill expands existing import exclusion and seizure authorities, allowing the Food and Drug Administration to refuse entry to and seize products that violate these new provisions, ensuring greater accountability and safety within the dietary supplement market.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2026

Latest Companion Bill Action

S 119-3797
Introduced in Senate
Feb 5, 2026
Introduced in House
Feb 5, 2026
Referred to the House Committee on Energy and Commerce.
  • February 5, 2026

    Latest Companion Bill Action

    S 119-3797
    Introduced in Senate


  • February 5, 2026
    Introduced in House


  • February 5, 2026
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • S 119-3797: Prohibiting Tianeptine and Other Dangerous Products Act of 2026

Prohibiting Tianeptine and Other Dangerous Products Act of 2026

USA119th CongressHR-7407| House 
| Updated: 2/5/2026
This bill amends the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts related to dietary supplements, aiming to enhance consumer protection and regulatory oversight. It specifically prohibits the introduction or delivery into interstate commerce of any product marketed as a dietary supplement that does not meet the statutory definition of a dietary supplement. This measure seeks to prevent mislabeled or non-compliant products from reaching consumers. Furthermore, the legislation makes it a prohibited act to introduce into commerce a dietary supplement that has been prepared, packed, or held with the assistance or direction of a person debarred under the Act. To strengthen enforcement, the bill expands existing import exclusion and seizure authorities, allowing the Food and Drug Administration to refuse entry to and seize products that violate these new provisions, ensuring greater accountability and safety within the dietary supplement market.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2026

Latest Companion Bill Action

S 119-3797
Introduced in Senate
Feb 5, 2026
Introduced in House
Feb 5, 2026
Referred to the House Committee on Energy and Commerce.
  • February 5, 2026

    Latest Companion Bill Action

    S 119-3797
    Introduced in Senate


  • February 5, 2026
    Introduced in House


  • February 5, 2026
    Referred to the House Committee on Energy and Commerce.
Frank Pallone

Frank Pallone

Democratic Representative

New Jersey

Energy and Commerce Committee

Health

Related Bills

  • S 119-3797: Prohibiting Tianeptine and Other Dangerous Products Act of 2026
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted